Physicochemical Characterization and Oral Dosage Form Design and Selection

[1]  B. Aungst.  Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. , 1993, Journal of pharmaceutical sciences.

[2]  R. Mannhold,et al.  Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds , 2009, Journal of pharmaceutical sciences.

[3]  J. Dressman,et al.  Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  Ranjita Shegokar,et al.  Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.

[5]  Fang Wang,et al.  Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs , 2012, Pharmaceutical Research.

[6]  Lawrence X. Yu,et al.  Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). , 2004, Advanced drug delivery reviews.

[7]  Hans Lennernäs,et al.  Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.

[8]  Joachim Grevel,et al.  Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation , 1994, Pharmaceutical Research.

[9]  Igor V. Tetko,et al.  How Accurately Can We Predict the Melting Points of Drug-like Compounds? , 2014, J. Chem. Inf. Model..

[10]  J. Devane.  Oral drug delivery technology : Addressing the solubility/permeability paradigm , 1998 .

[11]  Hugh N. Nellans,et al.  B) Mechanisms of peptide and protein absorption , 1991 .

[12]  G L Amidon,et al.  Solubility of nonelectrolytes in polar solvents. , 1972, Journal of pharmaceutical sciences.

[13]  Edyta Pindelska,et al.  Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques , 2017, Advanced drug delivery reviews.

[14]  R. Mannhold,et al.  Comparative evaluation of the predictive power of calculation procedures for molecular lipophilicity. , 1995, Journal of pharmaceutical sciences.

[15]  M. Gumbleton,et al.  In vivo evaluation of an oral self‐emulsifying drug delivery system (SEDDS) for exenatide , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Richard J. Bastin,et al.  Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities , 2000 .

[17]  Frank J. J. Leusen,et al.  Computer Simulation to Predict Possible Crystal Polymorphs , 2007 .

[18]  G Houin,et al.  Gastrointestinal absorption of drugs: methods and studies , 1999, Fundamental & Clinical Pharmacology.

[19]  D. Fatouros,et al.  Clinical studies with oral lipid based formulations of poorly soluble compounds , 2007, Therapeutics and clinical risk management.

[20]  Jennifer Dressman,et al.  A Refined Developability Classification System. , 2018, Journal of pharmaceutical sciences.

[21]  Roberto Gobetto,et al.  Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges , 2017, Advanced drug delivery reviews.

[22]  D. Grant,et al.  Influence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase. 2. Ampicillin , 1996 .

[23]  M. Brandl,et al.  Drug permeability profiling using cell-free permeation tools: Overview and applications. , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  Han van de Waterbeemd,et al.  Programs and Methods for Calculation of log P‐values , 1996 .

[25]  B. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids , 2004, Pharmaceutical Research.

[26]  A. Palmeira,et al.  Three decades of P-gp inhibitors: skimming through several generations and scaffolds. , 2012, Current medicinal chemistry.

[27]  Colin W. Pouton,et al.  Formulation of self-emulsifying drug delivery systems , 1997 .

[28]  R. Mannhold,et al.  Calculation Procedures for Molecular Lipophilicity: a Comparative Study† , 1996 .

[29]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[30]  G. Amidon,et al.  In vivo predictive dissolution: transport analysis of the CO2 , bicarbonate in vivo buffer system. , 2014, Journal of pharmaceutical sciences.

[31]  Hans Lennernäs,et al.  Permeability and clearance views of drug absorption: A commentary , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[32]  H. Meyer.  Zur Theorie der Alkoholnarkose , 1899, Archiv für experimentelle Pathologie und Pharmakologie.

[33]  B. Hirst,et al.  Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption , 1997 .

[34]  Harpreet S. Chadha,et al.  Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the delta log P parameter of seiler. , 1994, Journal of pharmaceutical sciences.

[35]  Keiji Sekiguchi,et al.  Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. , 1961 .

[36]  W. Charman,et al.  Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. , 2000, Journal of pharmaceutical sciences.

[37]  R. S. Hashim,et al.  Grid-based molecular modeling for pharmaceutical salt screening: Case example of 3,4,6,7,8,9-hexahydro-2H-pyrimido (1,2-a) pyrimidinium acetate. , 2006, Journal of pharmaceutical sciences.

[38]  M. Descamps.  Amorphous Pharmaceutical Solids. , 2016, Advanced drug delivery reviews.

[39]  David J Brayden,et al.  Intestinal permeation enhancers for oral peptide delivery. , 2016, Advanced drug delivery reviews.

[40]  David J.W. Grant,et al.  Solid-state pharmaceutical chemistry , 1994 .

[41]  Jennifer B Dressman,et al.  The developability classification system: application of biopharmaceutics concepts to formulation development. , 2010, Journal of pharmaceutical sciences.

[42]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[43]  Y Zhang,et al.  The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.

[44]  Lawrence X. Yu,et al.  Scientific Considerations of Pharmaceutical Solid Polymorphism in Abbreviated New Drug Applications , 2003, Pharmaceutical Research.

[45]  C. Pouton,et al.  Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.

[46]  Manfred Kansy,et al.  High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.

[47]  Bruno C. Hancock,et al.  Disordered drug delivery: destiny, dynamics and the Deborah number , 2002, The Journal of pharmacy and pharmacology.

[48]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[49]  D. Hauss.  Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.

[50]  R. Williams,et al.  Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update. , 2018, International journal of pharmaceutics.

[51]  Leslie Z. Benet,et al.  Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.

[52]  Christopher J. H. Porter,et al.  From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity , 2015, Nature Reviews Drug Discovery.

[53]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[54]  C. Porter,et al.  Lipophilic prodrugs designed for intestinal lymphatic transport , 1996 .

[55]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[56]  C. Porter,et al.  Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performance. , 2014, Journal of pharmaceutical sciences.

[57]  Margaret C. Etter,et al.  Hydrogen bonds as design elements in organic chemistry , 1991 .

[58]  J. Carstensen,et al.  Drug Stability, Revised, and Expanded : Principles and Practices , 2000 .

[59]  Colin W. Pouton,et al.  Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification , 1985 .

[60]  Kenneth R. Morris,et al.  Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development , 1994 .

[61]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[62]  F. Vrečer,et al.  Overview of solidification techniques for self-emulsifying drug delivery systems from industrial perspective. , 2017, International journal of pharmaceutics.

[63]  Christel A. S. Bergström,et al.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations , 2017, Pharmaceutical Research.

[64]  M. Bergren.  An automated controlled atmosphere microbalance for the measurement of moisture sorption , 1994 .

[65]  Christel A. S. Bergström,et al.  Automated assays for thermodynamic (equilibrium) solubility determination. , 2018, Drug discovery today. Technologies.

[66]  I. Sugimoto,et al.  Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. , 1988, Chemical & pharmaceutical bulletin.

[67]  Christopher J H Porter,et al.  Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.

[68]  Lokesh Kumar,et al.  An overview of automated systems relevant in pharmaceutical salt screening. , 2007, Drug discovery today.

[69]  Kerby Shedden,et al.  Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs. , 2017, Molecular pharmaceutics.

[70]  Orn Almarsson,et al.  Performance comparison of a co-crystal of carbamazepine with marketed product. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[71]  Christel A. S. Bergström,et al.  Understanding the Challenge of Beyond-Rule-of-5 Compounds. , 2016, Advanced drug delivery reviews.

[72]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[73]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[74]  D. Macfarlane,et al.  Crystalline vs. Ionic Liquid Salt Forms of Active Pharmaceutical Ingredients: A Position Paper , 2010, Pharmaceutical Research.

[75]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[76]  R. Borchardt,et al.  The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System , 1996, Pharmaceutical Research.

[77]  Chao-pin Lee,et al.  Selection of development candidates based on in vitro permeability measurements , 1997 .

[78]  W. Motherwell,et al.  Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.

[79]  H Lennernäs,et al.  Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.

[80]  Hans Lennernäs,et al.  Does Fluid Flow Across the Intestinal Mucosa Affect Quantitative Oral Drug Absorption? Is It Time for a Reevaluation? , 1995, Pharmaceutical Research.

[81]  A. Leo,et al.  Partition coefficients and their uses , 1971 .

[82]  O. H. Chan,et al.  Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in Humans , 1995, Pharmaceutical Research.

[83]  M. Hussain,et al.  Enhancement of the intestinal absorption of peptides and nonpeptides , 1996 .

[84]  A. Bernkop‐Schnürch,et al.  Mucoadhesive vs. mucopenetrating particulate drug delivery. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[85]  R. Holm,et al.  Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. , 2013, International journal of pharmaceutics.

[86]  A. Bansal,et al.  Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials. , 2014, Journal of pharmaceutical sciences.

[87]  Thomas J. Vidmar,et al.  A non-aqueous partitioning system for predicting the oral absorption potential of peptides , 1994 .

[88]  S. Chong,et al.  Cell culture-based models for intestinal permeability: a critique. , 2005, Drug discovery today.

[89]  U. Holzgrabe,et al.  'Pro et contra' ionic liquid drugs - Challenges and opportunities for pharmaceutical translation. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[90]  H. Lennernäs.  Gastrointestinal absorption mechanisms: a comparison between animal and human models , 1994 .

[91]  M. Odomi,et al.  Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[92]  N. Rodríguez-Hornedo,et al.  Pharmaceutical cocrystals and poorly soluble drugs. , 2013, International journal of pharmaceutics.

[93]  Kristina Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .

[94]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[95]  A. Bernkop‐Schnürch,et al.  Lipophilic peptide character - What oral barriers fear the most. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[96]  P York,et al.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. , 2007, Advanced drug delivery reviews.

[97]  Roger A. Rajewski,et al.  Cyclodextrins: Their Future in Drug Formulation and Delivery , 1997, Pharmaceutical Research.

[98]  Wei Sun,et al.  Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. , 2011, Journal of pharmaceutical sciences.

[99]  J. Tack,et al.  Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[100]  Patrick Augustijns,et al.  Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier. , 2012, Molecular pharmaceutics.

[101]  Gang Cheng,et al.  Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. , 2008, Drug discovery today.

[102]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.

[103]  O. H. Chan,et al.  Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .

[104]  G. Amidon,et al.  Physiological parameters for oral delivery and in vitro testing. , 2010, Molecular pharmaceutics.

[105]  Christel A. S. Bergström,et al.  Computational prediction of drug solubility in water-based systems: Qualitative and quantitative approaches used in the current drug discovery and development setting , 2018, International journal of pharmaceutics.

[106]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins: basic science and product development , 2010, The Journal of pharmacy and pharmacology.

[107]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[108]  Peter L D Wildfong,et al.  The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions. , 2018, Journal of pharmaceutical sciences.

[109]  H. Waterbeemd,et al.  Comparison of passive drug transport through Caco-2 cells and artificial membranes , 1997 .

[110]  M. Ticehurst,et al.  Application of slurry bridging experiments at controlled water activities to predict the solid-state conversion between anhydrous and hydrated forms using theophylline as a model drug. , 2002, International journal of pharmaceutics.

[111]  Christel A. S. Bergström,et al.  50years of oral lipid-based formulations: Provenance, progress and future perspectives. , 2016, Advanced drug delivery reviews.

[112]  Gordon L Amidon,et al.  In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases. , 2015, Journal of pharmaceutical sciences.

[113]  C. Lipinski,et al.  Physical parameters for brian uptake: optimizing log P, log D and pKa of T H A , 1991 .

[114]  J. Huuskonen,et al.  Estimation of aqueous solubility in drug design. , 2001, Combinatorial chemistry & high throughput screening.

[115]  Lynne S Taylor,et al.  Physical chemistry of supersaturated solutions and implications for oral absorption. , 2016, Advanced drug delivery reviews.

[116]  T. Loftsson,et al.  Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers. , 1998, Die Pharmazie.

[117]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[118]  Patrick Sandra,et al.  The utility of sulfonate salts in drug development. , 2010, Journal of pharmaceutical sciences.

[119]  Ning Shan,et al.  The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.

[120]  Absorption Enhancers: Applications and Advances , 2012, The AAPS Journal.

[121]  H Lennernäs,et al.  Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.

[122]  George Zografi,et al.  The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state , 1990 .

[123]  V. Stella,et al.  Prodrugs of phosphates, phosphonates, and phosphinates , 1996 .

[124]  David J Brayden,et al.  Safety concerns over the use of intestinal permeation enhancers: A mini-review , 2016, Tissue barriers.

[125]  S. Yalkowsky,et al.  Solubility and partitioning IV: Aqueous solubility and octanol-water partition coefficients of liquid nonelectrolytes. , 1981, Journal of pharmaceutical sciences.

[126]  David J Brayden,et al.  Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. , 2009, Advanced drug delivery reviews.

[127]  Bruno C. Hancock,et al.  The effect of temperature on water vapor sorption by some amorphous pharmaceutical sugars. , 1999, Pharmaceutical development and technology.

[128]  G. Amidon,et al.  Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir. , 2010, Molecular pharmaceutics.

[129]  Han van de Waterbeemd,et al.  Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .

[130]  S H Yalkowsky,et al.  Water solubility: a critique of the solvatochromic approach. , 1988, Journal of pharmaceutical sciences.

[131]  Aeri Park,et al.  The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.

[132]  W. Charman,et al.  Lipid-based vehicles for the oral delivery of poorly water soluble drugs , 1997 .

[133]  R. Ghadi,et al.  BCS class IV drugs: Highly notorious candidates for formulation development , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[134]  Christopher J H Porter,et al.  Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update☆ , 2007, Advanced Drug Delivery Reviews.

[135]  Donald C. Monkhouse,et al.  Review ArticlePharmaceutical Salts , 1977 .

[136]  K. Higashi,et al.  Recent progress of structural study of polymorphic pharmaceutical drugs. , 2017, Advanced drug delivery reviews.

[137]  D O Thompson,et al.  Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. , 1997, Critical reviews in therapeutic drug carrier systems.

[138]  C. Lehr,et al.  The role of mucus on drug transport and its potential to affect therapeutic outcomes☆ , 2017, Advanced drug delivery reviews.

[139]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[140]  A. Nokhodchi,et al.  Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges. , 2017, Advanced drug delivery reviews.

[141]  Martyn G. Ford,et al.  Simultaneous prediction of aqueous solubility and octanol/water partition coefficient based on descriptors derived from molecular structure , 2001, J. Comput. Aided Mol. Des..

[142]  Yahya E Choonara,et al.  A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. , 2014, Biotechnology advances.

[143]  Leslie Z. Benet,et al.  Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery , 1996 .

[144]  Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System , 2017, The AAPS Journal.

[145]  M. Al-Tabakha,et al.  Improving the high variable bioavailability of griseofulvin by SEDDS. , 2007, Chemical & pharmaceutical bulletin.

[146]  L. S. Taylor,et al.  Bile Salts as Crystallization Inhibitors of Supersaturated Solutions of Poorly Water-Soluble Compounds , 2015 .

[147]  D. Grant,et al.  Research paperInfluence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase. 1. Theophylline , 1996 .

[148]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[149]  A. Bernkop‐Schnürch,et al.  SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. , 2019, Advanced drug delivery reviews.

[150]  H. Sunada,et al.  Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. , 1997, Chemical & pharmaceutical bulletin.

[151]  K. Uekama.  [Pharmaceutical application of cyclodextrins as multi-functional drug carriers]. , 2004, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[152]  W. Rubas,et al.  Permeability Characteristics of Various Intestinal Regions of Rabbit, Dog, and Monkey , 1992, Pharmaceutical Research.

[153]  V. Nekkanti,et al.  Insoluble drug delivery strategies: review of recent advances and business prospects , 2015, Acta pharmaceutica Sinica. B.

[154]  Per Artursson,et al.  Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond , 1997, Pharmaceutical Research.

[155]  M. Faul,et al.  Salt form selection and characterization of LY333531 mesylate monohydrate. , 2000, International journal of pharmaceutics.

[156]  W. Rubas,et al.  Comparison of the Permeability Characteristics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug Absorption , 2004, Pharmaceutical Research.

[157]  M. Gumbleton,et al.  Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[158]  Amjad Alhalaweh,et al.  Bioavailability of indomethacin‐saccharin cocrystals , 2010, The Journal of pharmacy and pharmacology.

[159]  S. Velaga,et al.  Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization , 2008, Pharmaceutical Research.

[160]  K. Kohno,et al.  Surfactant effects on drug absorption. 3. Effects of sodium glycocholate and its mixtures with synthetic surfactants on absorption of thaimine disulfide compounds in rat. , 1974, Journal of pharmaceutical sciences.

[161]  J. Dressman,et al.  Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update , 2008, Pharmaceutical Research.

[162]  Yi Wang,et al.  Chapter 27. Ex vivo approaches to predicting oral pharmacokinetics in humans , 2000 .

[163]  H. Lennernäs,et al.  Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo , 1996 .

[164]  P. L. Gould,et al.  Salt selection for basic drugs , 1986 .

[165]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[166]  H Lennernäs,et al.  Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.

[167]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[168]  P. Royall,et al.  The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. , 1999, International journal of pharmaceutics.

[169]  Ulf Norinder,et al.  Molecular Descriptors Influencing Melting Point and Their Role in Classification of Solid Drugs , 2003, J. Chem. Inf. Comput. Sci..

[170]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[171]  Li Di,et al.  Bridging solubility between drug discovery and development. , 2012, Drug discovery today.

[172]  Kenneth R. Morris,et al.  An integrated approach to the selection of optimal salt form for a new drug candidate , 1994 .

[173]  Samuel H. Yalkowsky,et al.  Group Contribution Methods for Predicting the Melting Points and Boiling Points of Aromatic Compounds , 1994 .

[174]  S. Yalkowsky,et al.  Solubility and partitioning VI: octanol solubility and octanol-water partition coefficients. , 1983, Journal of pharmaceutical sciences.

[175]  P. Artursson.  Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.

[176]  Stephen Byrn,et al.  Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations , 1995, Pharmaceutical Research.

[177]  Jonathan Kenneth Embleton,et al.  Influence of lipolysis on drug absorption from the gastro-intestinal tract , 1997 .

[178]  B. Aungst,et al.  Intestinal permeation enhancers. , 2000, Journal of pharmaceutical sciences.

[179]  H Lennernäs,et al.  Jejunal permeability and hepatic extraction of fluvastatin in humans , 1996, Clinical pharmacology and therapeutics.

[180]  M. Rathbone,et al.  Amorphous Solid Dispersions , 2014, Advances in Delivery Science and Technology.

[181]  Christopher J. H. Porter,et al.  Computational prediction of formulation strategies for beyond-rule-of-5 compounds. , 2016, Advanced drug delivery reviews.

[182]  Lynne S Taylor,et al.  Evaluation of amorphous solid dispersion properties using thermal analysis techniques. , 2012, Advanced drug delivery reviews.

[183]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[184]  D. Richel,et al.  Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[185]  Bruno Sarmento,et al.  Amorphous solid dispersions: Rational selection of a manufacturing process. , 2016, Advanced drug delivery reviews.

[186]  Leslie Z Benet,et al.  Intestinal drug transporters: an overview. , 2013, Advanced drug delivery reviews.

[187]  Yong Cui.  A material science perspective of pharmaceutical solids. , 2007, International journal of pharmaceutics.

[188]  E. Wasan,et al.  Review and analysis of FDA approved drugs using lipid-based formulations , 2017, Drug development and industrial pharmacy.

[189]  P Buchwald,et al.  Octanol-water partition: searching for predictive models. , 1998, Current medicinal chemistry.

[190]  T. Loftsson,et al.  Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. , 2018, International journal of pharmaceutics.

[191]  Feng Qian,et al.  Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. , 2010, Journal of pharmaceutical sciences.

[192]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.

[193]  S. Faure,et al.  Models for drug absorption from the small intestine: where are we and where are we going? , 2017, Drug discovery today.

[194]  A. A. Rasool,et al.  Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. , 1991, Journal of pharmaceutical sciences.

[195]  P. Gao,et al.  Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.

[196]  Shiew-Mei Huang,et al.  Bioavailability and Bioequivalence: An FDA Regulatory Overview , 2001, Pharmaceutical Research.

[197]  S. Yalkowsky,et al.  Solubility and partitioning I: Solubility of nonelectrolytes in water. , 1980, Journal of pharmaceutical sciences.

[198]  Tu C Le,et al.  Aqueous solubility prediction: do crystal lattice interactions help? , 2013, Molecular pharmaceutics.

[199]  J. Kovarik,et al.  Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. , 1994, Journal of pharmaceutical sciences.

[200]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[201]  G. Flynn,et al.  Solubility of organic hydrochlorides. , 1972, Journal of pharmaceutical sciences.

[202]  N. Meanwell,et al.  The expanding role of prodrugs in contemporary drug design and development , 2018, Nature Reviews Drug Discovery.

[203]  S. Murdande,et al.  Development of a self-emulsifying formulation that reduces the food effect for torcetrapib. , 2008, International journal of pharmaceutics.

[204]  Elaine Merisko-Liversidge,et al.  Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.

[205]  H. Sunada,et al.  Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. , 1998, Chemical & pharmaceutical bulletin.

[206]  Lori R Hilden,et al.  Physics of amorphous solids. , 2004, Journal of pharmaceutical sciences.

[207]  B. Sarmento,et al.  Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review , 2014 .